Share |

professional

Career trajectories to the top: Where does the ideal family office leader come from?

August 3, 2021

The role of family office leader rarely becomes available and if it does unexpectedly, it can often fall on the shoulders of internal leaders to take charge—regardless of their specialism.

The role of family office leader rarely becomes available and if it does unexpectedly, it can often fall on the shoulders of internal leaders to take charge—regardless of their specialism.

FB Roundup: Mediterranean Shipping Company, EssilorLuxottica, Alberts Impact Capital

July 9, 2021

Aponte family expands its Mediterranean Shipping Company to rival Maersk, EssilorLuxottica proceeds with $8.7 billion stake in GrandVision after tribunal, Albert music publishing dynasty ventures into impact investing.

Aponte family expands its Mediterranean Shipping Company to rival Maersk

The Aponte family’s Mediterranean Shipping Company has re-energised its efforts to become the world’s largest container line by attempting to overtake rival family-controlled conglomerate AP Moller-Maersk.

Purpose, beliefs and behaviours: Which culture is your family office?

June 22, 2021

When trying to establish cultural fit in your family office, you must first think about your own culture. Defining your own organisational beliefs and the ideal qualities the ideal hire might possess.

When trying to establish cultural fit in your family office, you must first think about your own culture. Defining your own organisational beliefs and the ideal qualities the ideal hire might possess.

It is important to look at the gaps missing in your current resources, not simply from an academic and skills perspective, but also exploring the likes of emotional intelligence (EQ), personality and diversity of thought.

What is the impact of the family business on the family office?

May 12, 2021

Being heavily concentrated in a single area and/or business is often the backstory to the creation of wealth in many family instances. US Trust and Campden Research conducted a longitudinal study on family office investing and found that more than 70% of their sample identified that the source of the family wealth originated from the core family business, with 60% having an ongoing operating business.

Being heavily concentrated in a single area and/or business is often the backstory to the creation of wealth in many family instances. US Trust and Campden Research (1) conducted a longitudinal study on family office investing and found that more than 70% of their sample identified that the source of the family wealth originated from the core family business, with 60% having an ongoing operating business.

Managing wealth as a business: A family office—to be or not to be?

May 7, 2021

Does it make sense to professionalise the management of my wealth (or that of my family), treating it in a manner comparable to how I treat my company or other businesses? In other words, should we create a family office?

Plan rewards to retain your family office professionals

March 10, 2021

While investment bankers pull 100-hour weeks in an attempt to claw back any hope of a bonus this season, family office professionals are walking away with 100%, if not 200%, of their annual salary as bonus season closes a successful year for family offices.

Family offices cherry pick top executives in competitive Covid-19 labour market

October 5, 2020

Expanding family offices are finding themselves spoilt for choice in recruiting and retaining executive talent to help them navigate an increasingly complex and diversified investment space.

Expanding family offices are finding themselves spoilt for choice in recruiting and retaining executive talent to help them navigate an increasingly complex and diversified investment space.

Life-saving cancer breakthroughs are in the DNA of LXRepair

June 1, 2020

LXRepair will present to global investors its new approach to personalised cancer therapies at the Campden Wealth MedTech Investing Europe Conference in September 2020.

LXRepair will present to global investors its new approach to personalised cancer therapies at the Campden Wealth MedTech Investing Europe Conference in September 2020.

The French medtech company is pioneering the development of functional comprehensive DNA repair and DDR assay and has researched the science behind DNA repair mechanisms and in vitro diagnostics for cancer over the past 25 years.